跳至主要内容
临床试验/CTRI/2022/01/039180
CTRI/2022/01/039180已完成2/3 期

A randomized, controlled clinical study to compare efficacy of a polyherbal formulation (GP/PROD/2021/004) versus Standard Allopathic Formulation for relief of acutenonproductive cough and throat irritation

Mr Kamlesh Thummar2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年1月16日最近更新:

试验速览

阶段
2/3 期
状态
已完成
发起方
入组人数
60
试验地点
2
主要终点
1. Changes in day and night frequencies of cough from baseline to end of treatment period on a 6-point scale

研究概览

简要总结

The clinical study is planned to evaluate clinical effectiveness of a polyherbal formulation (GP/PROD/2021/004) versus StandardAllopathic Formulation for relief of acute nonproductive cough and throatirritation.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients with H/O acute nonproductive cough and throat irritation for less than 1week duration Males and Females between 18-65 years age Patients who in the opinion of the Investigator will be able to comply with the study requirements Patients with a cough score of 0, 1 or 2 during day time Patients willing and able to provide signed informed consent for any study related procedures.

排除标准

  • Patients with H/O lower respiratory tract infections such as Pneumonia, Tuberculosis, Bronchitis, Whooping cough.
  • Patients with H/O Chronic Obstructive Pulmonary Diseases/Asthma Patients with H/O underlying lung pathology such as lung abscess, cystic fibrosis.
  • Patients with known hypersensitivity to ingredients of Investigational Products Patients with clinical suspicion of any systemic bacterial infection.
  • Patients with H/O Myocardial Infarction (MI) within 4 weeks prior to enrollment Patients with immediate life threatening diseases such as pre-existing cardiovascular, liver or neoplastic disease.

结局指标

主要结局

1. Changes in day and night frequencies of cough from baseline to end of treatment period on a 6-point scale

时间窗: Baseline Day, Day 1, Day 2, Day 3, Day 4, Day 5, and Day 15

2. Change in throat irritation from baseline to end of treatment period on a 5-point scale

时间窗: Baseline Day, Day 1, Day 2, Day 3, Day 4, Day 5, and Day 15

次要结局

  • 1.Time to relief from cough and throat irritation on 5 point scale for first morning dose over a treatment period of 5 days(2.Duration of relief from symptoms on a 5 point scale for first morning dose over a treatment period of 5 days)

研究者

发起方
Mr Kamlesh Thummar
申办方类型
Other [director]

研究点 (2)

Loading locations...

相似试验